Flux Measurement and Outcome in Major Abdominal Surgery
NCT ID: NCT02612883
Last Updated: 2021-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
137 participants
OBSERVATIONAL
2015-11-18
2021-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: To assess the association of intraoperative flux measurement with postoperative outcome of patients undergoing major abdominal surgery.
Trial design: Prospective observational study. Flux measurement will be carried out using the moorVMS-LDF DUAL CHANNEL Laser Doppler Blood Flow system. The flux probe will be applied on the respective organs (i.e. esophagus, stomach, liver, pancreas, colon, rectum) and measurements will be documented after a stable signal has been obtained.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-time Quantitative Optical Perfusion Imaging in Surgery
NCT02902549
Peripheral and Mesenteric Perfusion in Elective Surgical Patients
NCT03395483
Fluid Challenges and Microcirculation
NCT04559178
Wound Perfusion in High Risk Surgical Incisions
NCT04233307
Blood Loss Quantification During Major Abdominal Surgery
NCT05316649
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Tissue perfusion is a critical factor for tissue regeneration and healing of anastomoses. Compromised microperfusion in the area where the anastomosis is sited likely contributes to leaks, but until now there has not been an easy and reliable technique to intraoperatively evaluate microperfusion.
During the post-operative period, inadequate wound perfusion and impairment of systemic or local oxygenation represent the main predisposing factors for anastomotic leakage. This is the case for the gastric conduit as well as for colonic/rectal anstomoses.
For example, the performance of gastroplasty has been shown to be associated with impairment in the microcirculatory blood flow in the proximal end of the gastric tube, despite the absence of significant impairment in systemic haemodynamic status.
These microcirculatory impairments promote the occurrence of oesophageal anastomotic leakage, which represents a potentially life-threatening complication related to the disastrous consequences of the leakage of gastrointestinal contents, with mediastinitis, septic shock, acute respiratory distress syndrome and death.
Similar results have been shown for colorectal anastomoses. So, a good microcirculatory blood flow around the anastomosis could indicate an optimal condition for anastomotic healing. Or the other way around, a bad microcirculatory blood flow could lead the surgeon to rethink the planned anastomosis.
Objectives: To assess the association of intraoperative flux measurement with postoperative outcome of patients undergoing major abdominal surgery.
Trial design: Prospective observational study. Flux measurement will be carried out using the moorVMS-LDF DUAL CHANNEL Laser Doppler Blood Flow system. The flux probe will be applied on the respective organs (i.e. esophagus, stomach, liver, pancreas, colon, rectum) and measurements will be documented after a stable signal has been obtained.
Laser Doppler measurement allows realtime and continuous monitoring suitable for the investigation of the gastrointestinal microcirculation. Light generated by a laser diode penetrates the tissue, where it is reflected by circulating blood cells. This reflected light is returned via an optical fibre to a photodetector and transformed into an electrical signal, which is proportional to the number of blood cells moving in the measured volume multiplied by the mean velocity of the cells, and is referred to as the blood flux expressed as perfusion units (PU).
Each measurement represents the mean value (PU) of a stable perfusion over a 1-min period without motion artefacts.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Esophagus
Measuring of tissue perfusion of the esophagus
No interventions assigned to this group
Liver
Measuring of tissue perfusion of the liver
No interventions assigned to this group
Stomach
Measuring of tissue perfusion of the stomach
No interventions assigned to this group
Pancreas
Measuring of tissue perfusion of the pancreas
No interventions assigned to this group
Colon
Measuring of tissue perfusion of the colon
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Liver resection
* Esophageal resection
* Gastric resection
* Colon/rectal resection
* Pancreatic resection
Exclusion Criteria
* Impaired mental state or language problems
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Reißfelder, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, TU Dresden, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, TU Dresden, Germany
Dresden, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VTG-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.